Literature DB >> 16282438

Accumulated chromosomal instability in murine bone marrow mesenchymal stem cells leads to malignant transformation.

Masako Miura1, Yasuo Miura, Hesed M Padilla-Nash, Alfredo A Molinolo, Baojin Fu, Vyomesh Patel, Byoung-Moo Seo, Wataru Sonoyama, Jenny J Zheng, Carl C Baker, Wanjun Chen, Thomas Ried, Songtao Shi.   

Abstract

Despite recent emerging evidence suggesting that cancer stem cells subsist in a variety of tumors, it is not yet fully elucidated whether postnatal stem cells are directly involved in tumorigenesis. We used murine bone marrow-derived mesenchymal stem cells (BMMSCs) as a model to test a hypothesis that tumorigenesis may originate from spontaneous mutation of stem cells. In this study, we demonstrated that murine BMMSCs, after numerous passages, obtained unlimited population doublings and proceeded to a malignant transformation state, resulting in fibrosarcoma formation in vivo. Transformed BMMSCs colonized to multiple organs when delivered systemically through the tail vein. Fibrosarcoma cells formed by transformed BMMSCs contained cancer progenitors, which were capable of generating colony clusters in vitro and fibrosarcoma in vivo by the second administration. The mechanism by which BMMSCs transformed to malignant cells was associated with accumulated chromosomal abnormalities, gradual elevation in telomerase activity, and increased c-myc expression. Moreover, BMMSCs and their transformed counterpart, fibrosarcoma-forming cells, demonstrated different sensitivity to anti-cancer drugs. BMMSCs/fibrosarcoma transformation system may provide an ideal system to elucidate the mechanism of how stem cells become cancer cells and to screen anti-sarcoma drugs.

Entities:  

Mesh:

Year:  2005        PMID: 16282438     DOI: 10.1634/stemcells.2005-0403

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  202 in total

Review 1.  Therapeutic applications of adipose-derived stem cells in cardiovascular disease.

Authors:  Kyle Bruun; Erika Schermer; Anjali Sivendra; Emily Valaik; Reed B Wise; Rana Said; John R Bracht
Journal:  Am J Stem Cells       Date:  2018-10-01

Review 2.  Modeling sarcomagenesis using multipotent mesenchymal stem cells.

Authors:  Rene Rodriguez; Ruth Rubio; Pablo Menendez
Journal:  Cell Res       Date:  2011-09-20       Impact factor: 25.617

Review 3.  Mesenchymal stromal cells for cell therapy: besides supporting hematopoiesis.

Authors:  Lei Hao; Huiqin Sun; Jin Wang; Tao Wang; Mingke Wang; Zhongmin Zou
Journal:  Int J Hematol       Date:  2011-12-20       Impact factor: 2.490

4.  Adipose-derived mesenchymal stromal cells from genetically modified pigs: immunogenicity and immune modulatory properties.

Authors:  Goutham Kumar; Hidetaka Hara; Cassandra Long; Humza Shaikh; David Ayares; David K C Cooper; Mohamed Ezzelarab
Journal:  Cytotherapy       Date:  2012-01-23       Impact factor: 5.414

Review 5.  Optimization of the cardiovascular therapeutic properties of mesenchymal stromal/stem cells-taking the next step.

Authors:  James D Richardson; Adam J Nelson; Andrew C W Zannettino; Stan Gronthos; Stephen G Worthley; Peter J Psaltis
Journal:  Stem Cell Rev Rep       Date:  2013-06       Impact factor: 5.739

6.  p53 in stem cells.

Authors:  Valeriya Solozobova; Christine Blattner
Journal:  World J Biol Chem       Date:  2011-09-26

7.  Chromosomal stability during ex vivo expansion of UCB CD34(+) cells.

Authors:  J Ge; H Cai; W S Tan
Journal:  Cell Prolif       Date:  2011-10-04       Impact factor: 6.831

Review 8.  Mesenchymal stem cells as feeder cells for pancreatic islet transplants.

Authors:  Valeria Sordi; Lorenzo Piemonti
Journal:  Rev Diabet Stud       Date:  2010-08-10

Review 9.  Bone marrow mesenchymal stem cells: historical overview and concepts.

Authors:  Pierre Charbord
Journal:  Hum Gene Ther       Date:  2010-09       Impact factor: 5.695

10.  Safety reporting on implantation of autologous adipose tissue-derived stem cells with platelet-rich plasma into human articular joints.

Authors:  Jaewoo Pak; Jae-Jin Chang; Jung Hun Lee; Sang Hee Lee
Journal:  BMC Musculoskelet Disord       Date:  2013-12-01       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.